Abstract
We evaluated the effect of syringe acquisition on syringe disposal among HIV-positive injection drug users (IDUs) in Baltimore, New York City, and San Francisco (N = 680; mean age 42 years, 62% male, 59% African-American, 21% Hispanic, 12% White). Independent predictors of safe disposal were acquiring syringes through a safe source and ever visiting a syringe exchange program. Weaker predictors included living in San Francisco, living in the area longer, less frequent binge drinking, injecting with an HIV+ partner, peer norms supporting safe injection, and self-empowerment. Independent predictors of safe “handling”—both acquiring and disposing of syringes safely—also included being from New York and being older. HIV-positive IDUs who obtain syringes from a safe source are more likely to safely dispose; peer norms contribute to both acquisition and disposal. Interventions to improve disposal should include expanding sites of safe syringe acquisition while enhancing disposal messages, alternatives, and convenience.
Similar content being viewed by others
References
Abdala, N., Stephens, P. C., Griffith, B. P., & Heimer, R. (1999). Survival of HIV-1 in syringes. Journal of Acquired Immune Deficiency Syndrome, 20, 73–80.
Barrera, M. A. (1980). A method for assessing social support networks in community survey research. Connections, 3, 8–13.
Broadhead, R. S., Van Hulst, Y., & Heckathorn, D. D. (1999). The impact of a needle exchange’s closure. Public Health Reports, 114, 439–447.
Burris, S., Welsh, J., Ng, M., Li, M., & Ditzler, A. (2002). State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. Journal of the American Pharmaceutical Association, 42(Suppl 2), S94–S98.
Caranci, P. F., Farmanian, R., Goldman, D., Kearns, C. M., LeBoeuf, K., Nicholson, R., Sands, R., & Scheraga, M. (2002). Eureka—implementing safe community needle disposal in Rhode Island. Journal of the American Pharmaceutical Association, 42(Suppl 2), S109–S110.
Centers for Disease Control and Prevention. (2005). Update: Syringe exchange programs—United States, 2002. MMWR, 54, 673–676.
Coffin, P.O. (2000). Syringe availability as HIV prevention: A review of modalities. Journal of Urban Health, 77, 302–326.
Crepaz, N., & Marks, G. (2002). Towards and understanding of sexual risk behavior in people living with HIV: A review of social, psychological and medical findings. AIDS, 16, 135–149.
Des Jarlais, D. C., Diaz, T., Perlis, T., Vlahov, D., Maslow, C., Latka, M., Rockwell, R., Edwards, V., Friedman, S. R., Monterroso, E., Williams, I., & Garfein, R. S. (2003). Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology, 157, 467–471.
Doherty, M. C., Garfein, R. S., Vlahov, D., Junge, B., Rathouz, P. J., Galai, N., Anthony, J. C., & Beilenson, P. (1997). Discarded needles do not increase soon after the opening of a needle exchange program. American Journal of Epidemiology, 145, 730–737.
Doherty, M. C., Junge, B., Rathouz, P., Garfein, R. S., Riley, E., & Vlahov, D. (2000). The effect of a needle exchange program on numbers of discarded needles: A 2 year follow-up. American Journal of Public Health, 90, 936–939.
Donoghoe, M. C., Stimson, G. V., & Dolan, K. (1992). Syringe exchange in England: An overview. London: The Tufnell Press.
Drda, B., Gomez, J., Conroy, R., Seid, M., & Michaels, J. (2002). San Francisco safe needle disposal program, 1991–2001. Journal of the American Pharmaceutical Association, 42(Suppl 2), S115–S116.
Fuller, C. M., Ahern, J., Vadnai, L., Coffin, P. O., Galea, S., Factor, S., & Vlahov, D. (2002). Impact of increased syringe access: Preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. Journal of the American Pharmaceutical Association, 42(Suppl 2), S77–S82.
Hart T. A., Wolitski, R. J., Purcell, D. W., Parsons, J. T., & Gomez, C. A. (2005). Seropositive Urban Men’s Study Team. Partner awareness of the serostatus of HIV-seropositive men who have sex with men: Impact on unprotected sexual behavior. AIDS and Behavior, 9(2), 155–166.
Jones, T. S., & Coffin, P. O. (2002). Preventing blood-borne infections through pharmacy syringes sales and safe community syringe disposal. Journal of the American Pharmaceutical Association, 42(Suppl 2), S6–S10.
Kaplan, E. H., & Heimer, R. A. (1994). Circulation theory of needle exchange. AIDS, 8(5), 567–574.
Kassler, W., & Ayotte, D. (2002). Deregulation of syringe sale and possession in New Hampshire, 1991–2000. Journal of the American Pharmaceutical Association, 42(Suppl 2), S19–S20.
Klein, S. J., Estel, G. R., Candelas, A. R., & Plavin, H. A. (2002). Promoting safe syringe disposal goes “hand in hand” with expanded syringe access in New York State. Journal of the American Pharmaceutical Association, 42(Suppl 2), S105–S107.
Latka, M. H., Mizuno, Y., Metsch, L., Wu, Y., Latkin, C., & Gomez, C. A. (2005). Who feels responsible for limiting the sexual transmission of HIV? A report from HIV-positive injection drug users enrolled in the INSPIRE project. Abstract presented at National HIV Prevention Conference, June 2005. Atlanta, GA.
Lurie, P., Jones, T. S., & Foley, J. (1998). A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 42 (Suppl 1), S45–S51.
Macalino, G. E., Springer, K. W., Rahman, Z. S., Vlahov, D., & Jones, T. S. (1998). Community-based programs for safe disposal of used needles and syringes. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl 1), S111–S119.
Marks, R. W., Hanrahan, M., Williams, D. H., Goldbaum, G., Thiede, H., & Wood, R. W. (2002). Encouraging pharmacy sale and safe disposal of syringes in Seattle, Washington. Journal of the American Pharmaceutical Association, 42(Suppl 2), S26–S27.
Myers, J. E., Eppes, S., Lentini, D., & Jones, T. S. (2002). Safe sharps disposal in public restrooms, Bush Intercontinental Airport, Houston, Texas. Journal of the American Pharmaceutical Association, 42(Suppl 2), S118–S119.
New York City Department of Health HIV/AIDS Surveillance Program. (2002). Semi-annual report with estimates of persons living with AIDS in New York City. New York: New York City Department of Health. .
Normand J., Vlahov D., Moses L. E. (Eds.). (1995) Preventing HIV transmission: The role of sterile needles and bleach. Washington, DC: National Academy of Medicine.
Novotny, G. A., Cotton-Oldenburg, N. U., Bond, B., & Tracy, B. (2002). The Minnesota pharmacy syringe access initiative: A successful statewide program to increase injection drug user access to sterile syringes. Journal of the American Pharmaceutical Association, 42(Suppl 2), S21–S22.
Oliver, K. J., Friedman, S. R., Maynard, H., Magnuson, L., & Des Jarlais, D. C. (1992). Impact of a needle exchange program on potentially infectious syringes in public places. Journal of Acquired Immune Deficiency Syndromes, 5, 380.
Olowokure, B., Duggal, H., & Armitage, L. (2003). The disposal of used sharps by diabetic patients living at home. International Journal of Environmental Health Research, 13, 117–123.
Purcell, D. W., Metsch, L. R., Latka, M., Santibanez, S., Gomez, C., Eldred, L., Latkin, C., & INSPIRE Study Group. (2004). Interventions for seropositive injectors-research and evaluation: An integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. Journal of Acquired Immune Deficiency Syndromes, 37(Suppl 2), S110–S118.
Rogers, E. S., Chamberlin, J., Ellison, M. L., & Crean, T. (1997). A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatric Services, 48, 1042–1047.
Sherman, S. G., Rusch, M., & Golub, E. T. (2004). Correlates of safe syringe acquisition and disposal practices among young IDUs: Broadening our notion of risk. Journal of Drug Issues, 34, 895–912.
Springer, K. W., Sterk, C. E., Jones, T. S., & Friedman, L. (1999). Syringe disposal options for injection drug users: A community-based perspective. Substance Use and Misuse, 34, 1917–1934.
Strasfeld, L., Lo, Y., Netski, D., Thomas, D. L., & Klein, R. S. (2003). The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. Journal of Acquired Immune Deficiency Syndromes, 33, 356–364.
Turnberg, W. L., & Jones, T. S. (2002). Community syringe disposal policies in 16 states. Journal of the American Pharmaceutical Association, 42(Suppl 2), S99–S104.
US Environmental Protection Agency. (2004). Community options for safe needle disposal. October 2004. EPA530-K-04−001. Available at: http://www.epa.gov/epaoswer/other/medical/med-govt.pdf. Accessed October 15, 2004.
Van Rossum, J. P., & Friederichs, J. (2002). Household sharps collection program, Brown County, Wisconsin. Journal of the American Pharmaceutical Association, 42(Suppl 2), S113–S114.
Wolfe, T., Amelunxen, V., Torres, D., Amelunxen, V., Torres, D., Jenison, S. & Churchill, J. (2002). Encouraging pharmacy sale of syringes to injection drug users in New Mexico. Journal of the American Pharmaceutical Association, 42(Suppl 2), S32–S33.
Wolitski, R. J., Bailey, C. J., O’Leary, A., Gomez, C. A. & Parsons, J. T. (2003). Self-perceived responsibility of HIV-seropositive men who have sex with men for preventing HIV transmission. AIDS and Behavior, 7, 363–372.
Acknowledgments
This study was supported by the Centers for Disease Control and Prevention and the Health Resources and Services Administration (CDC/HRSA grant U50CCU317999). We would also like to acknowledge the following people for their contributions to this research: Susan Sherman, Roeina Marvin, Joanne Jenkins, Donny Gann, and Tonya Johnson (Baltimore); Clyde McCoy, Rob Malow, Wei Zhao, Lauren Gooden, Sam Comerford, Virginia Locascio, Curtis Delford, Laurel Hall, Henry Boza, Cheryl Riles (Miami); George Fesser, Carol Gerran, and Diane Thornton (New York); Caryn Pelegrino, Barbara Garcia, Jeff Moore, Erin Rowley, Debra Allen, Dinah Iglesia-Usog, Gilda Mendez, Paul Lum, and Greg Austin (San Francisco); Gladys Ibanez, Hae-Young Kim, Toni McWhorter, Jan Moore, Lynn Paxton, and John Williamson (CDC); and Lee Lam, Jeanne Urban, Stephan Soroka, Zilma Rey, Astrid Ortiz, Sheila Bashirian, Marjorie Hubbard, Karen Tao, Bharat Parekh, Thomas Spira (CDC Laboratory).
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The INSPIRE Study Group includes the following people. Baltimore: Carl Latkin, Amy Knowlton, Karin Tobin; Miami: Lisa Metsch, Eduardo Valverde, James Wilkinson, Martina DeVarona; New York: Mary, Latka, Dave Vlahov, Phillip Coffin, Marc Gourevitch, Julia Arnsten, Robert Gern; San Francisco: Cynthia Gomez, Kelly Knight, Carol Dawson Rose, Starley Shade, Sonja Mackenzie; Centers for Disease Control and Prevention: David Purcell, Yuko Mizuno, Scott Santibanez, Richard Garfein, Ann O’Leary; Health Resources and Services Administration: Lois Eldred, Kathleen Handley.
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
Rights and permissions
About this article
Cite this article
Coffin, P.O., Latka, M.H., Latkin, C. et al. Safe Syringe Disposal is Related to Safe Syringe Access among HIV-positive Injection Drug Users. AIDS Behav 11, 652–662 (2007). https://doi.org/10.1007/s10461-006-9171-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-006-9171-x